417 related articles for article (PubMed ID: 1695318)
1. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
Ashby B
Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors.
Ashby B
Second Messengers Phosphoproteins; 1988; 12(1):45-57. PubMed ID: 2848122
[TBL] [Abstract][Full Text] [Related]
3. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities.
Ashby B
Mol Pharmacol; 1989 Dec; 36(6):866-73. PubMed ID: 2481225
[TBL] [Abstract][Full Text] [Related]
4. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
Miller OV; Gorman RR
J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
[TBL] [Abstract][Full Text] [Related]
5. Kinetic evidence indicating separate stimulatory and inhibitory prostaglandin receptors on platelet membranes.
Ashby B
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(4):291-300. PubMed ID: 2432105
[TBL] [Abstract][Full Text] [Related]
6. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
7. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
[TBL] [Abstract][Full Text] [Related]
8. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
[TBL] [Abstract][Full Text] [Related]
9. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
Jaschonek K; Renn W; Weisenberger H
Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
[TBL] [Abstract][Full Text] [Related]
10. Interactions among prostaglandin receptors.
Ashby B
Receptor; 1994; 4(1):31-42. PubMed ID: 8038705
[TBL] [Abstract][Full Text] [Related]
11. PGE1 but not PGI2 desensitizes the PGI2 receptor-adenylate cyclase complex in human foreskin fibroblasts.
Gorman RR; Hopkins NK
Adv Prostaglandin Thromboxane Res; 1980; 8():1717-21. PubMed ID: 6246790
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
13. Effect of thromboxane antagonists on prostaglandin regulation of platelet adenylate cyclase.
Ashby B
Second Messengers Phosphoproteins; 1988-1989; 12(5-6):241-50. PubMed ID: 2483174
[TBL] [Abstract][Full Text] [Related]
14. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
15. Effects of PGD2, PGE1, and PGI2-analogues on PGDF-release and aggregation of human gelfiltered platelets.
Stürzebecher S; Nieuweboer B; Matthes S; Schillinger E
Prog Clin Biol Res; 1989; 301():365-9. PubMed ID: 2477855
[No Abstract] [Full Text] [Related]
16. Receptor (norepinephrine), P-site (2',5'-dideoxyadenosine), and calcium-mediated inhibition of prostaglandin and forskolin-activated cyclic AMP-generating systems in human platelets.
Siegl AM; Daly JW
J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(3):229-45. PubMed ID: 2991349
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
Armstrong RA; Jones RL; MacDermot J; Wilson NH
Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets.
Ashby B
Prostaglandins; 1992 Mar; 43(3):255-61. PubMed ID: 1378640
[TBL] [Abstract][Full Text] [Related]
19. [Prostaglandin receptors and prostaglandin metabolism in the terminal circulation of the brain].
Wasinger T
Wien Klin Wochenschr; 1989 Dec; 101(23):821-4. PubMed ID: 2514495
[TBL] [Abstract][Full Text] [Related]
20. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
